← board
CNBX
distress 7/10 · high distress / dilution risk$0.000%today-86% from 52w high
Revenue
pre-revenue
Liquidity
$0M
Runway
0.1 yrs
Shares 1y
+190%
Price & events
-50.0% over 6M
CatalystRating changeDilutionFinancingdashed = today
+0.0%
1D
+0.0%
1W
-50.0%
1M
-75.0%
3M
-50.0%
6M
-82.1%
1Y
-98.7%
2Y
-100.0%
5Y
-100.0%
All
Overview
- Market Cap
- $160.58K
- Volume
- 20.00K
- 52 Week Range
- $0.00 – $0.00
- Total Shares
- 1.61B
- Float Shares
- 1.61B
- % Held by Insiders
- 0.05%
- % Held by Institutions
- 6.23%
- RVOL
- 0.00x
- Beta
- 0.69
Pipeline · 0 trials · 0 upcoming
| Readout | Phase | Drug | Indication | Enroll | Status |
|---|---|---|---|---|---|
| No pipeline trials tracked. | |||||
Catalyst news & presentations · 0
- No catalyst news yet.
Approved drugs (0)
- none — clinical-stage
Capital structure — dilution & financing
🔒 Top holders — Pro
Institutional ownership + quarter-over-quarter accumulation/trimming.
Upgrade to ProWall St ratings
no consensus
- no recent rating changes
Competitors
- none identified
Recent news
- none
Not financial advice. Data: ClinicalTrials.gov, SEC EDGAR, FINRA, Nasdaq, Yahoo.